Data from 2023 Sample Registration Survey shows India’s IMR has been declining faster than global rate. Delhi, Karnataka, Himachal lead in gains, but regional gaps persist.
CDSCO green light to Beyfortus, used to combat Respiratory Syncytial Virus, which is the leading cause for hospitalisation of kids under 2 years of age in India.
Findings come nearly a year after several Indian states had outbreaks. Reported measles incidence increased 72 percent worldwide in 2021-2022, says report.
According to the IVAC report, India’s coverage of pneumococcal conjugate vaccine, increased by 6 percentage points while rotavirus vaccine for diarrhoea, rose by 29 percentage points.
Drawing on experience of measles rubella campaign of 2017, govt estimates it could take between one-two months for states to complete the 30 crore targeted Covid vaccinations.
A World Bank, Duke University, UPenn study conducted across 120 gram panchayats in UP shows conducting public meetings can improve healthcare delivery.
Flucelvax, produced by Melbourne-based CSL’s Seqirus unit, is 36.2 % more effective than conventional shots in preventing flu-like illness that killed almost 200 American children last winter.
In the storm around Sinauli, many academics dismissed claims of chariots being found. And the public misinterpreted the chariots as a device planted by the govt to fortify Hindutva.
Naidu’s summit brings in MoUs on same scale as Jagan’s, but CM says his plans built on speed, certainty & investor trust, with escrow accounts, simplified incentives & real-time oversight.
Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.
COMMENTS